APO Research
Talk to an analyst

APO RESEARCH · REPORT

DXM and Codeine Syrup

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global DXM and Codeine Syrup Market Outlook and Growth Opportunities 2026

22 December 2025193 pages

Choose your research edition.

Industry ResearchDXM and Codeine Syrup Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal DXM and Codeine Syrup Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal DXM and Codeine Syrup Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal DXM and Codeine Syrup Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal DXM and Codeine Syrup Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global DXM and Codeine Syrup market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for DXM and Codeine Syrup is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for DXM and Codeine Syrup is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for DXM and Codeine Syrup is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the DXM and Codeine Syrup market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the DXM and Codeine Syrup market include Atley Pharmaceuticals, Vertical Pharmaceuticals, Pfizer, Merck, Novartis and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global DXM and Codeine Syrup market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of DXM and Codeine Syrup and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents DXM and Codeine Syrup sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the DXM and Codeine Syrup market size, projected growth trends, production technologies, key applications, and end-use industries.

DXM and Codeine Syrup Segment by Company

Atley Pharmaceuticals

Vertical Pharmaceuticals

Pfizer

Merck

Novartis

Johnson & Johnson

DXM and Codeine Syrup Segment by Type

DXM

Promethazine-codeine Cough Syrup

DXM and Codeine Syrup Segment by Application

Adult

Children

DXM and Codeine Syrup Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global DXM and Codeine Syrup status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions DXM and Codeine Syrup market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify DXM and Codeine Syrup significant trends, drivers, influence factors in global and regions.

6. To analyze DXM and Codeine Syrup competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global DXM and Codeine Syrup market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of DXM and Codeine Syrup and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of DXM and Codeine Syrup.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the DXM and Codeine Syrup market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global DXM and Codeine Syrup industry.

Chapter 3: Detailed analysis of DXM and Codeine Syrup manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of DXM and Codeine Syrup in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of DXM and Codeine Syrup in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. DXM and Codeine Syrup Industry Trends Table 2. DXM and Codeine Syrup Industry Drivers Table 3. DXM and Codeine Syrup Industry Opportunities and Challenges Table 4. DXM and Codeine Syrup Industry Restraints Table 5. Global DXM and Codeine Syrup Revenue by Company (US$ Million) & (2021-2026) Table 6. Global DXM and Codeine Syrup Revenue Share by Company (2021-2026) Table 7. Global DXM and Codeine Syrup Sales Volume by Company (k units) & (2021-2026) Table 8. Global DXM and Codeine Syrup Sales Volume Share by Company (2021-2026) Table 9. Global DXM and Codeine Syrup Average Price (US$/unit) of Company (2021-2026) Table 10. Global DXM and Codeine Syrup Company Ranking, (2024-2026) & (USD Million) Table 11. Global DXM and Codeine Syrup Key Company Manufacturing Base & Headquarters Table 12. Global DXM and Codeine Syrup Company, Product Type & Application Table 13. Global DXM and Codeine Syrup Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global DXM and Codeine Syrup by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of DXM Table 18. Significant Companies of Promethazine-codeine Cough Syrup Table 19. Global DXM and Codeine Syrup Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global DXM and Codeine Syrup Sales Volume by Type (2021-2026) & (k units) Table 21. Global DXM and Codeine Syrup Sales Volume by Type (2027-2032) & (k units) Table 22. Global DXM and Codeine Syrup Sales Volume Share by Type (2021-2026) Table 23. Global DXM and Codeine Syrup Sales Volume Share by Type (2027-2032) Table 24. Global DXM and Codeine Syrup Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global DXM and Codeine Syrup Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global DXM and Codeine Syrup Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global DXM and Codeine Syrup Sales Value Share by Type (2021-2026) Table 28. Global DXM and Codeine Syrup Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Adult Table 30. Significant Companies of Children Table 31. Global DXM and Codeine Syrup Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global DXM and Codeine Syrup Sales Volume by Application (2021-2026) & (k units) Table 33. Global DXM and Codeine Syrup Sales Volume by Application (2027-2032) & (k units) Table 34. Global DXM and Codeine Syrup Sales Volume Share by Application (2021-2026) Table 35. Global DXM and Codeine Syrup Sales Volume Share by Application (2027-2032) Table 36. Global DXM and Codeine Syrup Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global DXM and Codeine Syrup Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global DXM and Codeine Syrup Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global DXM and Codeine Syrup Sales Value Share by Application (2021-2026) Table 40. Global DXM and Codeine Syrup Sales Value Share by Application (2027-2032) Table 41. Global DXM and Codeine Syrup Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global DXM and Codeine Syrup Sales by Region (2021-2026) & (k units) Table 43. Global DXM and Codeine Syrup Sales Market Share by Region (2021-2026) Table 44. Global DXM and Codeine Syrup Sales by Region (2027-2032) & (k units) Table 45. Global DXM and Codeine Syrup Sales Market Share by Region (2027-2032) Table 46. Global DXM and Codeine Syrup Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global DXM and Codeine Syrup Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global DXM and Codeine Syrup Sales Value Share by Region (2021-2026) Table 49. Global DXM and Codeine Syrup Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global DXM and Codeine Syrup Sales Value Share by Region (2027-2032) Table 51. Global DXM and Codeine Syrup Market Average Price (US$/unit) by Region (2021-2026) Table 52. Global DXM and Codeine Syrup Market Average Price (US$/unit) by Region (2027-2032) Table 53. Global DXM and Codeine Syrup Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 54. Global DXM and Codeine Syrup Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global DXM and Codeine Syrup Sales by Country (2021-2026) & (k units) Table 56. Global DXM and Codeine Syrup Sales Market Share by Country (2021-2026) Table 57. Global DXM and Codeine Syrup Sales by Country (2027-2032) & (k units) Table 58. Global DXM and Codeine Syrup Sales Market Share by Country (2027-2032) Table 59. Global DXM and Codeine Syrup Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global DXM and Codeine Syrup Sales Value Market Share by Country (2021-2026) Table 61. Global DXM and Codeine Syrup Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global DXM and Codeine Syrup Sales Value Market Share by Country (2027-2032) Table 63. Atley Pharmaceuticals Company Information Table 64. Atley Pharmaceuticals Business Overview Table 65. Atley Pharmaceuticals DXM and Codeine Syrup Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Atley Pharmaceuticals DXM and Codeine Syrup Product Portfolio Table 67. Atley Pharmaceuticals Recent Development Table 68. Vertical Pharmaceuticals Company Information Table 69. Vertical Pharmaceuticals Business Overview Table 70. Vertical Pharmaceuticals DXM and Codeine Syrup Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Vertical Pharmaceuticals DXM and Codeine Syrup Product Portfolio Table 72. Vertical Pharmaceuticals Recent Development Table 73. Pfizer Company Information Table 74. Pfizer Business Overview Table 75. Pfizer DXM and Codeine Syrup Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Pfizer DXM and Codeine Syrup Product Portfolio Table 77. Pfizer Recent Development Table 78. Merck Company Information Table 79. Merck Business Overview Table 80. Merck DXM and Codeine Syrup Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Merck DXM and Codeine Syrup Product Portfolio Table 82. Merck Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis DXM and Codeine Syrup Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Novartis DXM and Codeine Syrup Product Portfolio Table 87. Novartis Recent Development Table 88. Johnson & Johnson Company Information Table 89. Johnson & Johnson Business Overview Table 90. Johnson & Johnson DXM and Codeine Syrup Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. Johnson & Johnson DXM and Codeine Syrup Product Portfolio Table 92. Johnson & Johnson Recent Development Table 93. Key Raw Materials Table 94. Raw Materials Key Suppliers Table 95. DXM and Codeine Syrup Distributors List Table 96. DXM and Codeine Syrup Customers List Table 97. Research Programs/Design for This Report Table 98. Authors List of This Report Table 99. Secondary Sources Table 100. Primary Sources List of Figures Figure 1. DXM and Codeine Syrup Product Image Figure 2. Global DXM and Codeine Syrup Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global DXM and Codeine Syrup Sales Value (2021-2032) & (US$ Million) Figure 4. Global DXM and Codeine Syrup Sales (2021-2032) & (k units) Figure 5. Global DXM and Codeine Syrup Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global DXM and Codeine Syrup Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. DXM Image Figure 10. Promethazine-codeine Cough Syrup Image Figure 11. Global DXM and Codeine Syrup Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global DXM and Codeine Syrup Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global DXM and Codeine Syrup Sales Volume Share by Type (2021-2032) Figure 14. Global DXM and Codeine Syrup Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global DXM and Codeine Syrup Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global DXM and Codeine Syrup Sales Value Share by Type (2021-2032) Figure 17. Adult Image Figure 18. Children Image Figure 19. Global DXM and Codeine Syrup Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global DXM and Codeine Syrup Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global DXM and Codeine Syrup Sales Volume Share by Application (2021-2032) Figure 22. Global DXM and Codeine Syrup Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global DXM and Codeine Syrup Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global DXM and Codeine Syrup Sales Value Share by Application (2021-2032) Figure 25. Global DXM and Codeine Syrup Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 26. Global DXM and Codeine Syrup Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global DXM and Codeine Syrup Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global DXM and Codeine Syrup Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America DXM and Codeine Syrup Sales Value (2021-2032) & (US$ Million) Figure 30. North America DXM and Codeine Syrup Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe DXM and Codeine Syrup Sales Value (2021-2032) & (US$ Million) Figure 32. Europe DXM and Codeine Syrup Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific DXM and Codeine Syrup Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific DXM and Codeine Syrup Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America DXM and Codeine Syrup Sales Value (2021-2032) & (US$ Million) Figure 36. South America DXM and Codeine Syrup Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa DXM and Codeine Syrup Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa DXM and Codeine Syrup Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt DXM and Codeine Syrup Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. DXM and Codeine Syrup Value Chain Figure 124. Manufacturing Cost Structure Figure 125. DXM and Codeine Syrup Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • DXM
  • Promethazine-codeine Cough Syrup
Applications
  • Adult
  • Children
Companies covered
  • Atley Pharmaceuticals
  • Vertical Pharmaceuticals
  • Pfizer
  • Merck
  • Novartis
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global DXM and Codeine Syrup Sales Value (2021-2032)
  4. 1.2.2 Global DXM and Codeine Syrup Sales Volume (2021-2032)
  5. 1.2.3 Global DXM and Codeine Syrup Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 DXM and Codeine Syrup Market Dynamics
  1. 2.1 DXM and Codeine Syrup Industry Trends
  2. 2.2 DXM and Codeine Syrup Industry Drivers
  3. 2.3 DXM and Codeine Syrup Industry Opportunities and Challenges
  4. 2.4 DXM and Codeine Syrup Industry Restraints
3 DXM and Codeine Syrup Market by Company
  1. 3.1 Global DXM and Codeine Syrup Company Revenue Ranking in 2025
  2. 3.2 Global DXM and Codeine Syrup Revenue by Company (2021-2026)
  3. 3.3 Global DXM and Codeine Syrup Sales Volume by Company (2021-2026)
  4. 3.4 Global DXM and Codeine Syrup Average Price by Company (2021-2026)
  5. 3.5 Global DXM and Codeine Syrup Company Ranking (2024-2026)
  6. 3.6 Global DXM and Codeine Syrup Company Manufacturing Base and Headquarters
  7. 3.7 Global DXM and Codeine Syrup Company Product Type and Application
  8. 3.8 Global DXM and Codeine Syrup Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global DXM and Codeine Syrup Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 DXM and Codeine Syrup Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 DXM and Codeine Syrup Market by Type
  1. 4.1 DXM and Codeine Syrup Type Introduction
  2. 4.1.1 DXM
  3. 4.1.2 Promethazine-codeine Cough Syrup
  4. 4.2 Global DXM and Codeine Syrup Sales Volume by Type
  5. 4.2.1 Global DXM and Codeine Syrup Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global DXM and Codeine Syrup Sales Volume by Type (2021-2032)
  7. 4.2.3 Global DXM and Codeine Syrup Sales Volume Share by Type (2021-2032)
  8. 4.3 Global DXM and Codeine Syrup Sales Value by Type
  9. 4.3.1 Global DXM and Codeine Syrup Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global DXM and Codeine Syrup Sales Value by Type (2021-2032)
  11. 4.3.3 Global DXM and Codeine Syrup Sales Value Share by Type (2021-2032)
5 DXM and Codeine Syrup Market by Application
  1. 5.1 DXM and Codeine Syrup Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global DXM and Codeine Syrup Sales Volume by Application
  5. 5.2.1 Global DXM and Codeine Syrup Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global DXM and Codeine Syrup Sales Volume by Application (2021-2032)
  7. 5.2.3 Global DXM and Codeine Syrup Sales Volume Share by Application (2021-2032)
  8. 5.3 Global DXM and Codeine Syrup Sales Value by Application
  9. 5.3.1 Global DXM and Codeine Syrup Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global DXM and Codeine Syrup Sales Value by Application (2021-2032)
  11. 5.3.3 Global DXM and Codeine Syrup Sales Value Share by Application (2021-2032)
6 DXM and Codeine Syrup Regional Sales and Value Analysis
  1. 6.1 Global DXM and Codeine Syrup Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global DXM and Codeine Syrup Sales by Region (2021-2032)
  3. 6.2.1 Global DXM and Codeine Syrup Sales by Region: 2021-2026
  4. 6.2.2 Global DXM and Codeine Syrup Sales by Region (2027-2032)
  5. 6.3 Global DXM and Codeine Syrup Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global DXM and Codeine Syrup Sales Value by Region (2021-2032)
  7. 6.4.1 Global DXM and Codeine Syrup Sales Value by Region: 2021-2026
  8. 6.4.2 Global DXM and Codeine Syrup Sales Value by Region (2027-2032)
  9. 6.5 Global DXM and Codeine Syrup Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America DXM and Codeine Syrup Sales Value (2021-2032)
  12. 6.6.2 North America DXM and Codeine Syrup Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe DXM and Codeine Syrup Sales Value (2021-2032)
  15. 6.7.2 Europe DXM and Codeine Syrup Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific DXM and Codeine Syrup Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific DXM and Codeine Syrup Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America DXM and Codeine Syrup Sales Value (2021-2032)
  21. 6.9.2 South America DXM and Codeine Syrup Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa DXM and Codeine Syrup Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa DXM and Codeine Syrup Sales Value Share by Country, 2025 VS 2032
7 DXM and Codeine Syrup Country-level Sales and Value Analysis
  1. 7.1 Global DXM and Codeine Syrup Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global DXM and Codeine Syrup Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global DXM and Codeine Syrup Sales by Country (2021-2032)
  4. 7.3.1 Global DXM and Codeine Syrup Sales by Country (2021-2026)
  5. 7.3.2 Global DXM and Codeine Syrup Sales by Country (2027-2032)
  6. 7.4 Global DXM and Codeine Syrup Sales Value by Country (2021-2032)
  7. 7.4.1 Global DXM and Codeine Syrup Sales Value by Country (2021-2026)
  8. 7.4.2 Global DXM and Codeine Syrup Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt DXM and Codeine Syrup Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt DXM and Codeine Syrup Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt DXM and Codeine Syrup Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Atley Pharmaceuticals
  2. 8.1.1 Atley Pharmaceuticals Company Information
  3. 8.1.2 Atley Pharmaceuticals Business Overview
  4. 8.1.3 Atley Pharmaceuticals DXM and Codeine Syrup Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Atley Pharmaceuticals DXM and Codeine Syrup Product Portfolio
  6. 8.1.5 Atley Pharmaceuticals Recent Developments
  7. 8.2 Vertical Pharmaceuticals
  8. 8.2.1 Vertical Pharmaceuticals Company Information
  9. 8.2.2 Vertical Pharmaceuticals Business Overview
  10. 8.2.3 Vertical Pharmaceuticals DXM and Codeine Syrup Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Vertical Pharmaceuticals DXM and Codeine Syrup Product Portfolio
  12. 8.2.5 Vertical Pharmaceuticals Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer DXM and Codeine Syrup Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer DXM and Codeine Syrup Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
  19. 8.4 Merck
  20. 8.4.1 Merck Company Information
  21. 8.4.2 Merck Business Overview
  22. 8.4.3 Merck DXM and Codeine Syrup Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Merck DXM and Codeine Syrup Product Portfolio
  24. 8.4.5 Merck Recent Developments
  25. 8.5 Novartis
  26. 8.5.1 Novartis Company Information
  27. 8.5.2 Novartis Business Overview
  28. 8.5.3 Novartis DXM and Codeine Syrup Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Novartis DXM and Codeine Syrup Product Portfolio
  30. 8.5.5 Novartis Recent Developments
  31. 8.6 Johnson & Johnson
  32. 8.6.1 Johnson & Johnson Company Information
  33. 8.6.2 Johnson & Johnson Business Overview
  34. 8.6.3 Johnson & Johnson DXM and Codeine Syrup Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Johnson & Johnson DXM and Codeine Syrup Product Portfolio
  36. 8.6.5 Johnson & Johnson Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 DXM and Codeine Syrup Value Chain Analysis
  2. 9.1.1 DXM and Codeine Syrup Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 DXM and Codeine Syrup Sales Mode & Process
  6. 9.2 DXM and Codeine Syrup Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 DXM and Codeine Syrup Distributors
  9. 9.2.3 DXM and Codeine Syrup Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst